Fatemeh Tavakoli1, Sara Aghaee2, Hamid Sharifi1, Aryan Esmaeili1,3, Ali Akbar Haghdoost1, Willi McFarland3, Ali Mirzazadeh1,3. 1. HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. 2. Kaiser Permanente Division of Research, Oakland, CA, USA. 3. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Abstract
Background: In this study, we sought to determine factors relating to initiating injection drug use before the age of 18 years in Iran. Methods: In this cross-sectional survey, people who inject drugs were recruited using facility-based sampling in 10 cities in Iran in 2014. Adults (≥18 year) who reported injecting drugs at least one time during the last year were included. A structured questionnaire collected behaviors related to injection, sexual risk, and HIV testing. Based on the reported age of first injection, we grouped participants into that initiating injection drug use by before 18-year old versus 18- and after 18-year old. Results: Of 2356 participants, 199 (8.5%, 95% CI 7.4-9.6) started injecting before the age of 18 years. Initiating injection drug use before the age of 18 years were more likely to be <30-year old (39.4% vs. 19.7%, p < .001), report syringe and needle sharing (15.0% vs. 5.4%, p < .001), have sex with other men (24.3% vs. 15.6%, p < .001), and have complete knowledge about HIV (92.5% vs. 86.4%, p < .001). Conclusion: People who started injection at younger ages had higher risk profiles and should be prioritized for substance use treatment, harm reduction, and HIV prevention programs.
Background: In this study, we sought to determine factors relating to initiating injection drug use before the age of 18 years in Iran. Methods: In this cross-sectional survey, people who inject drugs were recruited using facility-based sampling in 10 cities in Iran in 2014. Adults (≥18 year) who reported injecting drugs at least one time during the last year were included. A structured questionnaire collected behaviors related to injection, sexual risk, and HIV testing. Based on the reported age of first injection, we grouped participants into that initiating injection drug use by before 18-year old versus 18- and after 18-year old. Results: Of 2356 participants, 199 (8.5%, 95% CI 7.4-9.6) started injecting before the age of 18 years. Initiating injection drug use before the age of 18 years were more likely to be <30-year old (39.4% vs. 19.7%, p < .001), report syringe and needle sharing (15.0% vs. 5.4%, p < .001), have sex with other men (24.3% vs. 15.6%, p < .001), and have complete knowledge about HIV (92.5% vs. 86.4%, p < .001). Conclusion:People who started injection at younger ages had higher risk profiles and should be prioritized for substance use treatment, harm reduction, and HIV prevention programs.
Entities:
Keywords:
Injection before the age of 18; Iran; people who inject drugs
Authors: Meredith Becker Buxton; David Vlahov; Steffanie A Strathdee; Don C Des Jarlais; Edward V Morse; Lawrence Ouellet; Peter Kerndt; Richard S Garfein Journal: Drug Alcohol Depend Date: 2004-08-16 Impact factor: 4.492
Authors: Crystal M Fuller; Luisa N Borrell; Carl A Latkin; Sandro Galea; Danielle C Ompad; Steffanie A Strathdee; David Vlahov Journal: Am J Public Health Date: 2005-04 Impact factor: 9.308
Authors: Jeanne Abelson; Carla Treloar; June Crawford; Susan Kippax; Ingrid van Beek; John Howard Journal: Addiction Date: 2006-04 Impact factor: 6.526
Authors: Zahra Jorjoran Shushtari; Alireza Noroozi; Ali Mirzazadeh; Elahe Ahounbar; Ahmad Hajbi; Mohammad Najafi; Ali Bazrafshan; Mohammad Hossin Farhadi; Ali Farhoudian; Peter Higgs; Farahnaz Mohammadi Shahboulagh; Katherine Waye; Mehdi Noroozi Journal: Subst Use Misuse Date: 2017-02-03 Impact factor: 2.164
Authors: Crystal M Fuller; David Vlahov; Danielle C Ompad; Nina Shah; Amelia Arria; Steffanie A Strathdee Journal: Drug Alcohol Depend Date: 2002-04-01 Impact factor: 4.492
Authors: Sonya Arreola; Ricky N Bluthenthal; Lynn Wenger; Daniel Chu; James Thing; Alex H Kral Journal: Drug Alcohol Depend Date: 2014-02-26 Impact factor: 4.492